Acknowledgements
We gratefully acknowledge the voluntary donations of peripheral blood
and leukapheresis samples used in this study. This study was supported
by the staff of the Scottish National Blood Transfusion Service (SNBTS)
Clinical Apheresis Unit, Aberdeen and medical colleagues at the New
Zealand Blood Transfusion Service for collection of the donor
leukapheresis material for the second iteration of the EBV-T cell bank.
This work was supported by a Wellcome Trust Translational Award. The
ongoing operation of the UK EBV-specific T cell bank is supported by
cost-recovery fees and supported by SNBTS.